会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • CHELANT COMPOUNDS
    • 化合物
    • WO1995028392A1
    • 1995-10-26
    • PCT/GB1995000833
    • 1995-04-12
    • NYCOMED IMAGING A/SCOCKBAIN, JulianVARADARAJAN, JohnWATSON, Alan, DavidBERG, Arne
    • NYCOMED IMAGING A/SCOCKBAIN, Julian
    • C07D257/02
    • A61K49/06C07C237/08C07D255/02C07D257/02C07D259/00C07D273/00
    • The invention provides amphiphilic compounds of the formula (I) Ch-(-L-Ar-(-AH)n)m (where Ch is a hydrophilic chelant moiety or a salt or a chelate thereof); each L is an optionally oxo substituted C2-25-alkylene linker wherein at least one CH2 moiety is replaced by a group X (e.g. L may include a chain sequence, an X (CH2CH2X )u (where u is a positive integer) such as X CH2CH2X , CH2X CH2CH2X CH2CH2X , CH2X CH2CH2X CH2CH2X CH2CH2X , etc.), and wherein L is optionally interrupted by a metabolizable group M but with the provisos that the terminus of L adjacent Ch is CH2 and that the terminus of L adjacent Ar is X or a CH2 group adjacent or separated by one CH2 from a group X (thus, for example the L-Ar linkage may be L -X -Ar, L -CH2-Ar, L -X CH2-Ar or L -X CH2CH2-Ar, where L is the residue of L; each Ar is an aryl ring optionally substituted by or having fused thereto a further aryl ring; each AH is a protic acid group, preferably an oxyacid, e.g. a carbon, sulphur or phosphorus oxyacid or a salt thereof; each X is O, S, NR or PR , preferably no more than 3 X groups being present in L; each R is hydrogen, alkyl or aryl; and m and n are positive integers, m being for example 1 to 4, especially 1 or 2 and n being for example 1, 2 or 3) which are especially suited for use in diagnostic imaging of the hepatobiliary system.
    • 本发明提供式(I)Ch - ( - L-Ar - ( - AH)n)m(其中Ch是亲水性螯合剂部分或其盐或螯合物)的两亲化合物; 每个L是任选氧代取代的C2-25-亚烷基接头,其中至少一个CH 2部分被基团X 1取代(例如L可以包括链序列,X 1(CH 2 CH 2 X 1)u( 其中u是正整数),例如X 1 CH 2 CH 2 X 1,CH 2 X 1 CH 2 CH 2 X 1 CH 2 CH 2 X 1,CH 2 X 1 CH 2 CH 2 X 1 CH 2 CH 2 X 1 CH 2 CH 2 X 1等 ),并且其中L任选地被可代谢基团M中断,但条件是邻近Ch的L的末端是CH 2,并且L相邻的Ar的末端是X 1或与一个CH 2相邻或分隔的CH2基团 基团X 1(因此,例如L-Ar键可以是L 1 -X 1 -Ar,L 1 -CH 2 -Ar,L 1 -X 1 CH 2 - Ar或L 1 -X 1 CH 2 CH 2 -Ar,其中L 1是L的残基;每个Ar是任选被另外的芳基环取代或与其稠合的芳基;每个AH是质子酸 基团,优选含氧酸,例如碳,硫或磷的含氧酸或其盐;每个X 1为O,S,NR 1或PR 1,优选不超过3个X 1为 存在于 升; 每个R 1是氢,烷基或芳基; m和n为正整数,m为例如1至4,特别是1或2,n为例如1,2或3),其特别适用于肝胆系统的诊断成像。
    • 3. 发明申请
    • POLYAZACYCLOALKANES AS DICHELANTS
    • 聚四环素作为狄更斯
    • WO1995009848A2
    • 1995-04-13
    • PCT/GB1994002115
    • 1994-09-29
    • NYCOMED SALUTAR, INC.COCKBAIN, Julian, Roderick, MichaelsonCARVALHO, JoanFELLMANN, Jere, DouglasWATSON, Alan, DavidKOO, Michael
    • NYCOMED SALUTAR, INC.COCKBAIN, Julian, Roderick, Michaelson
    • C07D257/02
    • C07D295/15A61K49/122C07D257/02C07D273/08C07D403/14C07F9/6524
    • This invention relates to dichelants, in particular compounds having two macrocyclic chelant groups linked by a bridge containing an ester or amide bond, especially compounds of formula (V) (wherein each X which may be the same or different is NZ, O or S, at least two Xs being NZ; each Z is a group R or a group CR 2Y, at least one Z, and preferably 2 or 3 Zs, on each macrocyclic ring being a group CR 2Y; each Y is a group CO2H, PO3H, SO3H, CONR 2, CON(OR )R , CNS or CONR NR 2, preferably COOH; m is 0 or 1 or 2, preferably 1; each n is 2 or 3, preferably 2; q is 1 or 2, preferably 1; each R which may be the same or different is a hydrogen atom or an alkyl group optionally substituted by one or more hydroxy and/or alkoxy groups; and D is a bridging group, other than an unsubstituted carbonylaminoethylaminocarbonyl group, having a molecular weight of less than 1000, preferably less than 500, joining two macrocyclic rings via at least one amide or ester bond) and salts and metal chelates thereof.
    • 本发明涉及双耳,特别是具有通过含有酯或酰胺键的桥连接的两个大环螯合剂基团的化合物,特别是具有式(Ⅴ)化合物(其中每个X可以相同或不同的是NZ,O或S, 至少两个X为NZ;每个Z为基团R 1或基团CR 1 2Y,至少一个Z,优选2或3个Z,每个大环上为基团CR 2Y; 每个Y是CO 2 H,PO 3 H,SO 3 H,CONR 2,CON(OR 1)R 1,CNS或CONR 1 NR 1,优选COOH; m是0或1或 2,优选1;每个n为2或3,优选2; q为1或2,优选1;每个R 1可以相同或不同,是氢原子或任选被一个或多个 羟基和/或烷氧基; D是分子量小于1000,优选小于500的未取代的羰基氨基乙基氨基羰基以外的桥连基,通过至少一个酰胺键或酯键连接两个大环)和盐 和金属螯合物。